Sign up
Two older men are drinking coffee and chatting in a conservatory
Brain Closed for registration

LUMA

This study tests the safety and efficacy of BIIB122 in people with early-stage Parkinson's disease. The drug is taken orally and compared with a placebo.
Age 30 - 80 years
Stadium Early stage Parkinson's disease (maximum 2 years after diagnosis)
Duration 55 to 151 weeks
Location Amsterdam or Zwolle

Who can participate in this study?

Fixed conditions apply to this research. The following are stated in plain language.

You can participate if

  • You have the diagnosis of Parkinson's disease in the early stage
  • You are between 30 and 80 years old

If you are unsure whether you meet these requirements, you can always register. We will then look together to see if you are suitable to participate.

Consultation with us

What is this research about?

The aim of this study is to determine how safe and effective the new drug BIIB122 is for the treatment of participants with the early stage of Parkinson’s disease. We compare the efficacy of the new drug BIIB122 with that of a placebo (a drug without an active ingredient, a ‘dummy drug’). The investigational drug is administered orally.

This study examines whether the drug BIIB122 can help slow down the progression of the disease. Microglia cells are activated by inflammation; several studies have shown that overactivating these cells is harmful to the brain and may play a role in Parkinson’s disease. BIIB122 reduces the activation of microglia cells.

You will visit the research center approximately 9 to 20 times, over approximately 55 to 151 weeks. The duration of the study and the number of visits depend on when you start the study. The duration of each visit is not always the same because not all visits involve the same tests. Some of these visits are 6 hours long, others are 3.5 hours or shorter. The study takes place in Amsterdam and Zwolle; you choose the location that suits you best. If you wish, someone you know well or a family member can accompany you to the visits.

This research is being conducted on behalf of Biogen.

What you can expect from us

  • You are always the first priority – everything we do revolves around you.
  • Experienced team of doctors, neuropsychologists and nurses.
  • Open and welcoming atmosphere – this makes you feel at home quickly and allows you to relax.
  • Clarity – an expert in drug research, ensuring that you are well informed throughout all steps and that you can always contact us if you have any questions.

What does it bring me?

  • You may experience positive effects from a new treatment.
  • You will be under the control of a specialized team of healthcare professionals. They can provide you with advice and monitor whether there is a change in your daily functioning.
  • You actively contribute to the development of medicines for brain diseases

This is how to participate, step by step

1

You register

A two-minute form: name, phone number, email address, place of residence and diagnosis. No medical questions. You are only asking for information with this form.

An older woman sits at the kitchen table at home with a tablet and smiles

Costs

  • Joining doesn't cost you anything.
  • Travel and parking costs are reimbursed.
  • If you come during lunchtime, you will receive a meal.
  • Participation is outside your health insurance; your own contribution is not charged.

Take the first step

Two minutes, at home. After registering, you will hear from us within a week.

Where is this research being conducted?

This research is being conducted at two of our three locations. You choose the location that works best for you.

Amsterdam

Amsterdam

Cronenburg 2, 1081 GN Amsterdam

020 301 7170
Zwolle

Zwolle

Dokter Stolteweg 90, 8025 AZ Zwolle

038 202 6120

Frequently asked questions

I am already taking other medications; can I continue taking them?

Yes, you can continue to use your current medications. After your registration, we will carefully review your current medication use. If you use many (heavy) medications, that may be a reason not to allow you to participate in a study, but this varies per study. In no case should you stop using your current medications.

Will the regular treatment continue under my current specialist during participation in drug trials? Or will Progress Clinical Research take over this responsibility?

The regular treatment by your current specialist will generally continue during the period of the investigation. Progress Clinical Research will inform your specialist and your GP about your participation. During the investigation, checks will be performed at several points. If there are any abnormalities in the results, Progress Clinical Research, with your consent, will contact your GP or treating specialist. Your GP or specialist is also welcome to consult with one of our research doctors regarding changes in your health.

Does Progress Clinical Research also seek participants without symptoms or without a diagnosis to participate in drug trials?

Progress Clinical Research mainly conducts research on patients who have already been diagnosed, but we sometimes also conduct studies where healthy volunteers are sought. So you can also sign up if no diagnosis has been made.

Can I stop the research early or are there any conditions attached?

Yes, stopping can be done at any time. There are no conditions attached to this.

Progress Clinical Research has several drug trials: can I choose which trial I am interested in?

Yes, you can read about the ongoing studies on our website. You can also indicate a preference for a particular study: for example, would you prefer to participate in a short study (for example, a few months) or a long study (for example, several years)? Progress Clinical Research determines, among other things, based on your medical history, age, and current medication use whether you are suitable for the study of your preference. Different criteria apply for each study, and the possibilities are discussed with the study doctor. Participation in a study is always done in consultation.

What does participating in a study actually mean?

Steps to follow when participating in research:

  • Sign up Sign up with Progress Clinical Research.
  • Telephone intake and request of medical history You will be called for a telephone intake, information about Progress Clinical Research will be sent to you and you will receive a form to sign in order to request the medical history from the treating physician (this history is necessary to determine whether you are eligible for the study).
  • Choosing an introductory meeting and a study: If your medical history with Progress Clinical Research shows no objections to participating in the study, we schedule an introductory meeting of approximately half an hour with the pre-screening specialist and the study doctor. In this meeting, we will get to know each other in more detail and mutually express preferences and expectations. Next, you will receive detailed information about a number of drug studies to take home, so that you can read it calmly at home and possibly discuss it with family or friends. Then you choose which study you would like to participate in.
  • Screening During the screening, various tests are performed to determine whether you are eligible to participate in the drug trial. Sometimes the examination only involves a series of questions, while other tests may require laboratory tests. These tests are always performed in consultation with and with your consent. This screening takes between one and a half to three hours and varies depending on the drug trial. Based on the results, it is determined whether you are eligible to participate in the chosen drug trial or not. Since each trial has different criteria for participation, you may be eligible to participate in another trial. Each trial has different criteria for participation.
  • Randomization In drug research, some of the patients receive the active drug. The other part of the patients receives a placebo. A placebo is a drug without active ingredients. The patients are randomly placed in a group by a computer. Both the patients and the Brain Research Center do not know who is in which group. This way, the research results can be compared well: does the group that receives the real drug perform the same, better, or worse than the placebo group? As soon as the drug study is completed by all participants, you will be informed whether you received the active drug or the placebo.
  • Follow-up appointments: Once the screening has been completed, follow-up appointments are scheduled. The number of appointments and the duration of the appointments vary per drug study. On average, patients come to Progress Clinical Research 1 to 2 times per month for a half-hour to several hours visit. At Progress Clinical Research, you will receive more information during the initial meeting. The documentation that you receive when you leave the clinic also includes how often you visit the Brain Research Center during the study. When scheduling the appointments, we of course take as much into account as possible regarding your and your partner’s work schedules and vacation plans, but we also ask for flexibility on your part.
  • After the investigation: Once you have gone through the entire investigation, the results are reviewed: Have you remained stable, moved forward, or actually regressed? Subsequently, we can decide together whether to continue with an investigation or conclude your period of employment with Progress Clinical Research.
Can I participate in a study more often?

Yes, that is possible. If you have completed the entire study, the results are reviewed: Have you remained stable, progressed, or actually regressed? Subsequently, we can decide together whether to continue with the study or conclude your period of employment at Progress Clinical Research.

Is there a financial reimbursement for patients?

All patients receive reimbursement for travel and parking costs automatically. Lunch is also provided for longer visits. There is no other financial reimbursement. You participate in a clinical drug trial because the medicines offer you the chance to improve and because you want to help future generations. Another benefit of participating in a research study is that your disease is monitored closely and you receive good guidance and support from professionals during the study.

What does randomization mean?

In some clinical drug trials, some of the patients receive the active drug. The other part of the patients receives a placebo. A placebo is a drug without active substances. The patients are randomly placed in a group by a computer. Both the patients and the doctors do not know who is in which group. However, there are also drug trials where no placebo is used; all the patients receive the study drug.

What does blindness mean?

A computer randomly places the patients in a group. One group receives the active drug, the other group receives a placebo. A placebo is a drug without active ingredients. No one involved in the research knows which group you belong to. This is called blinding.

What do the medicines look like?

The investigational medication often comes in the form of tablets. You can take them at home daily. Depending on the type of drug being studied, the medication may also be administered every few weeks via an injection or infusion. This is done at Progress Clinical Research under the supervision of a doctor.

Do I always have a chance of getting a placebo?

In most drug trials, there is indeed a medicinal product that is active and a medicinal product that is not active (placebo). Progress Clinical Research has no control over the allocation of the funds: this happens automatically and Progress Clinical Research does not receive that information either. Only in acute emergencies can Progress Clinical Research request this information. There are also a number of drug trials that use only active substances. During an initial consultation, the research doctor can inform you about this.

Will my health insurance’s deductible be applied if I participate in a study by Progress Clinical Research?

No, the treatments at Progress Clinical Research are not covered by health insurance. Therefore, you do not have to worry about any out-of-pocket costs. For each drug trial, an individual insurance policy is taken out for all participants. If you have any questions about this, please ask during the initial consultation or during the initial meeting. Please note that other matters, such as follow-up visits with your own specialist (outside of Progress Clinical Research), are still covered by your own health insurance.

Other studies about the Brain

All studies

Is this research not relevant? These studies within the same disease area are now also looking for participants.

An older man and his son are looking at a photo album together on the sofa Brain

Parkinson 1B BP45361

This research section investigates the safety and efficacy of RO7568282 in people with Parkinson's disease…

Parkinson 40 - 75 years Amsterdam Zwolle Den Bosch

*Would you prefer to call? We will take the time to answer your questions.

An older woman is sitting smilingly at her kitchen table Brain

Alzheimer BMS CN0120052

In this study, we examine whether KarXT, together with KarX-EC, can help people with...

Alzheimer 60 - 85 years old Amsterdam Den Bosch Zwolle

*Would you prefer to call? We will take the time to answer your questions.

An elderly couple is looking at documents together at the table Brain

MINDSET-1 DUTCH

For people with MCI or mild Alzheimer's, a BMI of 18–40 and an MMSE score of 12–22.…

Alzheimer 60 - 85 years old Amsterdam Den Bosch Zwolle

*Would you prefer to call? We will take the time to answer your questions.